FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically dermatology, and may be used for treating the patients with atopic dermatitis. That is ensured by narrow-range medium-wave UV light of the range B at wave length 311 nm with underlying supportive care. It is added with prescribing the preparation heparin in the form of subcutaneous injections in a therapeutic dose of 5000 IU 4 times a day daily for 14 days.
EFFECT: method provides higher clinical effectiveness and prolonged remission.
3 tbl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ALLERGIC DERMATITIS TREATMENT | 2008 |
|
RU2365392C1 |
METHOD OF TREATING GUTTATE PSORIASIS | 2011 |
|
RU2483762C2 |
METHOD OF TREATING PSORIASIS VULGARIS | 2011 |
|
RU2472541C1 |
METHOD OF PSORIASIS TREATMENT | 2008 |
|
RU2391122C1 |
WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716617C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716616C1 |
METHOD FOR TREATING ATOPIC DERMATITIS CASES | 2006 |
|
RU2300402C1 |
APPLICATION OF SEMAX PREPARATION FOR TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2347582C1 |
METHOD FOR TREATING ATOPIC DERMATITIS | 2001 |
|
RU2199304C1 |
Authors
Dates
2012-12-10—Published
2011-04-15—Filed